Table 1

Correlation between PPA, steroid content or chronic recurrence and subfoveal choroidal structure at 1 week after treatment

Increase of the PPA area from 1 week (mm2)Total dose of corticosteroid (mg)Eyes with chronic recurrences (n=10)Eyes without chronic recurrences (n=24)OR (95% CI) and p value
Luminal area at 1 week (mm2)B=0.091 (per 0.1 mm2)
Embedded Image=4.67
p=0.0306		B=417.261 (per 0.1 mm2)
Embedded Image=2.24
p=0.1342		0.5159±0.14510.4181±0.1110OR=1.89 (0.80 to 4.45)
p=0.1446
Stromal area at 1 week (mm2)B=−0.008 (per 0.01 mm2)
Embedded Image=0.14
p=0.7111		B=−57.512 (per 0.01 mm2)
Embedded Image=0.24
p=0.6226		0.1762±0.03520.1812±0.0334OR=0.96 (0.73 to 1.26)
p=0.7450
Total choroidal area at 1 week (mm2)B=0.059 (per 0.1 mm2)
Embedded Image=2.18
p=0.1396		B=259.680 (per 0.1 mm2)
Embedded Image=1.19
p=0.2746		0.6921±0.17610.5993±0.1393OR=1.51 (0.74 to 3.09)
p=0.2611
L/S ratio at 1 weekB=0.042 (per 0.1)
Embedded Image=38.46
p<0.0001		B=212.435 (per 0.1)
Embedded Image=8.41
p=0.0037		2.908±0.4632.297±0.268OR=1.37 (1.15 to 1.65)
p=0.0006
Choroidal thickness at 1 week (μm)B=0.090 (per 100 μm)
Embedded Image=2.22
p=0.1360		B=398.790 (per 100 μm)
Embedded Image=1.21
p=0.2722		462.7±117.7400.0±91.8OR=1.89 (0.63 to 5.65)
p=0.2577

  • The data are displayed as mean±SD. Total dose of corticosteroid, total dose of intravenously or orally administered corticosteroid during 52 weeks (prednisolone equivalent). B, regression coefficients; L/S ratio, ratio of luminal area to stromal area; PPA, peripapillary atrophy; Embedded Image, Wald χ2 statistics.